- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------------------
FORM 8-K
--------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): NOVEMBER 3, 2004
-----------------------
MICROTEK MEDICAL HOLDINGS, INC.
-------------------------------
(Exact name of registrant as specified in its charter)
-------------------------
GEORGIA 0-24866 58-1746149
------- ------- ----------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
512 LEHMBERG ROAD, COLUMBUS, MISSISSIPPI 39702
----------------------------------------------
(Address of principal executive office) (zip code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (662) 327-1863
-------------------------------------------------------------
(Former name or former address, if changed since last report)
-------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
- --------------------------------------------------------------------------------
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On November 3, 2004, Microtek Medical Holdings, Inc. (the "Company") issued
a press release reporting its operating results for the quarter and period
ended September 30, 2004. This press release is attached as Exhibit 99.1 to
this report and is incorporated herein by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements.
N/A
(b) Pro Forma Financial Information.
N/A
(c) Exhibits.
Exhibit Number Description
-------------- -----------
99.1 Press release dated November 3, 2004, reporting the
Company's operating results for the quarter and
period ended September 30, 2004
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MICROTEK MEDICAL HOLDINGS, INC.
Date: November 3, 2004 By: /s/ Dan R. Lee
-------------------------------------
Dan R. Lee, Chairman, President and
Chief Executive Officer
By: /s/ Roger G. Wilson
-------------------------------------
Roger G. Wilson, Chief Financial
Officer
3
EXHIBIT INDEX
Exhibit Number Description
99.1 Press release dated November 3, 2004, reporting the
Company's operating results for the quarter and period
ended September 30, 2004
4